Maternal exposure to sleep aids and risk of specific birth defects in the Birth Defects Study To Evaluate Pregnancy exposureS.
STUDY OBJECTIVES: Insomnia symptoms are often reported during pregnancy, prompting use of pharmacologic treatments. We explored associations between treatments used during the month before through the third month of pregnancy ("early pregnancy") and risk of birth defects using Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS) data from 2014-2021. METHODS: Pregnancies affected by birth defects ("cases") were identified from surveillance systems in seven states; liveborn infants without birth defects ("controls") were randomly selected from the same catchment areas. Mothers of cases and controls reported early pregnancy exposures via interview, including use of prescription, over-the-counter, or herbal sleep aids. For defects with ≥5 exposed cases, we used Firth's logistic regression to estimate propensity score-adjusted odds ratios (aORs) and 95% confidence intervals (CIs), adjusting for maternal age, race/ethnicity, education, body mass index, previous live birth, history of depression/anxiety, early pregnancy use of antipsychotics, anxiolytics, antidepressants, opioids, cigarettes, alcohol, and prenatal vitamins, occurrence of stressful events, occupation outside the home, health insurance, and site. RESULTS: Overall, 237 (7%) cases and 140 (8%) controls reported early pregnancy sleep aid use. We calculated aORs for 12/22 defects, which ranged from 0.52 for d-transposition of the great arteries to 1.61 for coarctation of the aorta. All CIs included the null. CONCLUSIONS: Results suggest sleep aids do not increase risk of most defects studied, but increased risk for coarctation of the aorta cannot be ruled out. Small numbers limited analyses. Studies examining the severity of underlying sleep disorders and impacts of specific sleep aids would be beneficial.
Authors
- Melissa Tracy (ORCID: https://orcid.org/0000-0003-3209-0197)
- Elizabeth C. Ailes (ORCID: https://orcid.org/0000-0003-2062-8148)
- Eva M. Williford (ORCID: https://orcid.org/0000-0003-3609-5665)
- Sarah C. Fisher (ORCID: https://orcid.org/0000-0002-4702-1007)
- Eleni A. Papadopoulos (ORCID: https://orcid.org/0000-0003-4355-7557)
- Jennita Reefhuis (ORCID: https://orcid.org/0000-0002-4747-4831)
- Meredith M. Howley (ORCID: https://orcid.org/0000-0002-8420-5040)
- Martha M. Werler (ORCID: https://orcid.org/0000-0003-3392-6814)
Institutions
- Boston University (US)
- Centers for Disease Control and Prevention (US)
- New York State Department of Health (US)
- University at Albany, State University of New York (US)
- National Center on Birth Defects and Developmental Disabilities (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1093/sleep/zsag297
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00